ArticleCurrent therapeutic research, clinical and experimental2022

Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study.

Young Rock Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.